{
    "clinical_study": {
        "@rank": "8124", 
        "arm_group": {
            "arm_group_label": "Patients diagnosed with bipolar disorder I or II"
        }, 
        "brief_summary": {
            "textblock": "The objective of the ambispective cohort study is to describe clinical management and\n      clinical outcomes related to bipolar disorder in China, and establish the factors associated\n      with different management patterns and clinical outcomes, provide psychiatrists with\n      reliable and up-to-date information on the disease."
        }, 
        "brief_title": "Observation Study of the Clinical Management of Bipolar Disorder", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Bipolar Disorder", 
        "condition_browse": {
            "mesh_term": "Bipolar Disorder"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Provision of subject informed consent.\n\n          -  Diagnosis of Bipolar Disorder I or II (DSM-IV TR) in any phase of the disorder.\n\n          -  Patients who had at least one mood event( depression, mania, hypomania or mixed)\n             according to DSM-IV TR definition during the 3 and 12 months prior to the beginning\n             of the study.\n\n        Exclusion Criteria:\n\n          -  Inability to complete Patient Reported Outcomes (PROs) questionnaires.\n\n          -  Participation in an interventional clinical study in last 12 months."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients diagnosed with bipolar disorder I or II with at least one mood event during the 3\n        and 12 months prior to the beginning of the study."
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01770704", 
            "org_study_id": "NIS-NCN-XXX-2012/1"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Bipolar disorder", 
            "Clinical management", 
            "Clinical outcomes"
        ], 
        "lastchanged_date": "April 1, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shenzhen", 
                        "country": "China", 
                        "state": "Guangdong"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai"
                    }, 
                    "name": "Reserach Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Xi'an", 
                        "country": "China", 
                        "state": "Shanxi"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kunming", 
                        "country": "China", 
                        "state": "Yunnan"
                    }, 
                    "name": "Research SIte"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hangzhou", 
                        "country": "China", 
                        "state": "Zhejiang"
                    }, 
                    "name": "Research Site"
                }
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "official_title": "Chinese Observation Study of the Clinical Management of Bipolar Disorder", 
        "overall_official": [
            {
                "affiliation": "Beijing No.6 Hospital", 
                "last_name": "Yu Xin", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Capital Medical University", 
                "last_name": "Wang Gang", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: China Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of episodes (depression, mania, hypomania or mixed).", 
            "safety_issue": "No", 
            "time_frame": "Up to 21 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01770704"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Treatments received for Bipolar Disorder: medication time.", 
                "safety_issue": "No", 
                "time_frame": "Up to 21 months"
            }, 
            {
                "measure": "Treatments received for Bipolar Disorder: medication classes.", 
                "safety_issue": "No", 
                "time_frame": "Up to 21 months"
            }
        ], 
        "source": "AstraZeneca", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AstraZeneca", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Observational Model: Cohort", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}